decreased this blank rate without adversely affecting catalase activity.
The residual blank reaction was corrected by use of a separate blank assay. Although successful, this approach does require additional steps and decreases the extent of automation.
We found that the coupled-enzyme method gave somewhat different values from those obtained with the manual method, as shown by the slope of the regression line. Although the results were correlated, the 340-nm method appears to demonstrate a somewhat greater sensitivity to changes in catalase activity in the hemolysate. This may be related to inherent differences in the response of the peroxidatic and catalatic reactions in this method, as compared with the catalatic reaction alone, as the catalase concentration in erythrocytes changes. Unfortunately, wide application of measurements of antioxidant enzyme activity has been somewhat limited by the tedious nature of the assays. The most commonly used spectrophotometric method for catalase in erythrocytes requires a spectrophotometer capable of measuring absorbance at 240 nm and involves adjustment of initial conditions (7) . Thus partition fluorescent immunoassay (StratusTM) system demonstrated a positive interference with some icteric samples (4, 5) . In contrast, we observed no interference from lutropin, follitropin, choriogonadotropin, lipemia, or moderate hemolysis. We therefore attempted to assess whether the apparent increase of TSH was related to an abnormality of hepatic function. Our objectives were to identif' patients who exhibit falsely increased TSH values and to correlate the discrepancy with biochemical markers of liver function.
Materials and Methods
The sensitive Stratus TSH assay material was provided by Dade (Miami, FL). A second, "nonsensitive" radioimmunoassay (RJA) for TSH was performed with a kit purchased from Diagnostic Products (Los Angeles, CA Figure 2 shows the scatterplot of the difference between the observed Stratus TSH concentration and the leastsquares predicted concentration (regression line in Figure  1 ) as a function of ALP activity.
As illustrated, some increased ALP values are associated with large differences between observed and predicted TSH (shown by plus signs). The estimated slope of the relationship is 0.0029 (SD 0.00024). Thus, on average, every 100 U/L change in ALP activity is associated with a 0.29 milli-int. unit/L difference between the observed and expected Stratus TSH concentration. ALP as an independent factor accounted for 33.6% of the residual variability about the regression line of Stratus vs RIA TSH concentration (Figure 1 ). However, several samples with increased ALP activity exhibited no significant difference between observed and predicted TSH.
A three-dimensional plot of Stratus TSH, RIA TSH, and ALP ( Figure 3) shows that an increased ALP activity is frequently, but not invariably, associated with samples for which TSH values are higher by the Stratus assay than by the RIA.
We tested a few patients' samples with apparent falsely increased TSH values in the Stratus TSH assay system by using an anti-/3-choriogonadotropin antibody-coated tab instead of anti-TSH-coated tabs. When measured against an antibody that does not recognize TSH, these samples also gave falsely high values, expressed as TSH.
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Discussion
During our initial evaluation of an automated assay capable of analyzing large numbers of samples, we observed a positive interference in the icteric samples that did not correlate with bilirubin concentration (4, 5) . This positive interference could result in a failure to detect hyperthyroid patients, as well as lead to falsely diagnosing some euthyroid patients as hypothyroid.
We undertook a new study to determine the cause of the positive assay bias, which we postulated was related to an abnormality of hepatic function. This study confirms our previous observation that falsely increased TSH values are independent of T. Bil concentration.
Another liver-function test, GGT, also does not correlate with the falsely increased TSH values. However, some of the observed TSH discrepancy appears to be related to an increased activity of ALP in the patients.
The concentration of ALP does not predict absolutely whether the interference will be present (see Figure 2) , because some samples with markedly increased ALP values fail to demonstrate falsely increased TSH. A similar interference has been observed in the Stratus method for creatine kinase MB isoenzyme (7) and may be associated with a high-molecular-mass form of ALP that is membrane bound. In both our study (4, 5) and that of Butch et al. (7) , increases of ALP could not account for all the falsely increased TSH values. Dade has modified the substrate wash solution to correct the problem of ALP interference for the MB assay by including a better inhibitor of human ALP. However, this product is not available for the TSH assay.
The evaluation of biochemical markers of liver function demonstrates that increases in ALP partly explain the positive bias for Stratus TSH values when compared with a nonsensitive RIA method. However, we are unable to explain the false increases for all patients' samples in which TSH discrepancies are noted. Until this problem is corrected, TSH values measured by the Stratus assay should be interpreted with caution when determined for patients with hepatic dysfunction.
